Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2019-06-11 Capital/Financing Update
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC AG resolves to issue new shares to continue to advance its drug development programs for resminostat and domatinostat
Capital/Financing Update Classification · 1% confidence The document is an Ad-hoc announcement dated June 11, 2019, detailing that 4SC AG's Management Board resolved to conduct a cash capital increase via a rights offering to existing shareholders to raise funds for drug development programs. This action involves issuing new shares and changing the capital structure. This directly aligns with the definition of 'Capital/Financing Update' (CAP), which covers company fundraising and capital structure changes. It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV). While it involves shares, the core action is the financing/capital raise, making CAP the most precise fit over SHA (Share Issue/Capital Change), as the primary context is the fundraising strategy.
2019-06-11 English
4SC AG: 4 upcoming conferences
Report Publication Announcement Classification · 1% confidence The document is a short press release dated May 16, 2019, announcing that 4SC AG will participate in four upcoming financial and scientific conferences between May 20 and June 21, 2019. It lists the names and dates of these events. This type of announcement, which informs the market about management's schedule for investor engagement (meetings at conferences), does not fit neatly into the specific categories like Earnings Release (ER), Interim Report (IR), or Capital Update (CAP). It is a general corporate update regarding investor relations activities. Since it is a general announcement that doesn't fit a more specific category, the most appropriate fallback is Regulatory Filings (RNS), as it is a standard news release disseminated via a service like DGAP.
2019-05-16 English
4SC provides Q1 2019 update
Earnings Release Classification · 1% confidence The document is titled "4SC provides Q1 2019 update" and explicitly states it is the "Q1 Announcement 2019". It covers material developments up to March 31, 2019, and includes a section on the "Development of cash balance in Q1 2019". This content structure—a periodic update focusing on financial highlights and operational progress for a period shorter than a year (Q1)—is characteristic of an Interim/Quarterly Report. Although it is an 'announcement' of the report, the text provides substantial detail on financials and business outlook, making it more than just a brief RPA/RNS notice. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). Q1 2019
2019-04-18 English
Q1 statement / Q1 financial report 2019
Management Reports Classification · 1% confidence The document is titled "Q1 Announcement 2019" and provides a business review for the first quarter ending March 31, 2019, including updates on clinical studies (RESMAIN, SENSITIZE, EMERGE) and financial information (cash balance as of March 31, 2019, and cash burn rate). This structure—a comprehensive update on operational and financial performance for a period shorter than a year—is characteristic of an Interim or Quarterly Report (IR). Although it references the Annual Report 2018, the content itself is a detailed quarterly review, not just a brief announcement of a report's publication (which would suggest RPA or RNS).
2019-04-18 English
4SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.05.2019 in Planegg-Martinsried mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 1% confidence The document is titled 'Bekanntmachung der Einberufung zur Hauptversammlung am 24.05.2019' (Announcement of the Convocation for the Annual General Meeting on 05/24/2019) and explicitly invites shareholders to the 'ordentlichen Hauptversammlung der 4SC AG' (Ordinary General Meeting of 4SC AG). The agenda items (Tagesordnung) include standard AGM topics like approving financial statements, discharging management/supervisory boards, and voting on capital structure changes (e.g., creating new conditional capital). This content directly corresponds to the purpose of an Annual General Meeting (AGM) announcement/materials. Therefore, the classification is AGM-R.
2019-04-12 German
Datum:11.04.2019
Management Reports Classification · 1% confidence The document is a 'Zusammengefasster Lagebericht' (Combined Management Report) for the fiscal year 2018 for 4SC AG. It provides a detailed review of business operations, R&D activities (Resminostat, Domatinostat, 4SC-208), market outlook, and economic developments. This content is characteristic of the Management Discussion and Analysis (MDA) section of an annual report, which provides the narrative explanation of financial results and business strategy.
2019-04-11 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.